by Sue Robbins | Jul 28, 2020 | Migraine
In patients with episodic migraine, erenumab provided sustained efficacy for the condition over the course of 1 year, according to new results from a study to evaluate the efficacy and safety of erenumab in migraine prevention (STRIVE), published in Neurology....
by Sue Robbins | Jan 15, 2020 | Migraine
A systematic review and meta-analysis of data collected from observational cohort studies reveals several clinical and sociodemographic factors are predictors of chronic migraine. The study, published in the International Headache Society’s Cephalalgia, looked at...
by Sue Robbins | Jan 14, 2020 | Migraine
In a study published December 26 in the Journal of Clinical Medicine, researchers tested the effects of cathodal transcranial direct current stimulation (tDCS) in the occipital cortex of 42 patients with episodic migraine. They determined that tDCS applied to this...
by Sue Robbins | Jun 23, 2015 | Headache Drugs
A pain-relieving gel for treating migraine appears safe and effective, and may provide a new treatment option. In a phase 2a clinical trial, 48 adults with episodic migraine with and without aura treated 5 migraines by applying the gel Topofen on the skin over the 3...
by Sue Robbins | Sep 25, 2014 | Headache Drugs
“Mast cell degranulation or parasympathetic hyperactivity, as encountered with asthma, might predispose an individual to the future onset of chronic migraine,” said Vincent Martin, MD, Professor of Medicine at the University of Cincinnati. The findings are...
